Literature DB >> 29698703

Predominance of ST5-II-t311 clone among healthcare-associated methicillin-resistant Staphylococcus aureus isolates recovered from Zhejiang, China.

Dandan Wu1, Zhengan Wang2, Haiping Wang2, Lu Sun2, Yan Chen3, Shujuan Ji2, Keren Shi2, Yunsong Yu4.   

Abstract

OBJECTIVES: To determine the molecular characteristics and antimicrobial susceptibility of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Zhejiang Province.
METHODS: A total of 391 HA-MRSA isolates were collected from 12 hospitals in five cities of Zhejiang Province, between January 2012 and May 2013. Susceptibility to vancomycin, teicoplanin, linezolid, tigecycline, and daptomycin was determined. Resistant isolates were screened for resistance mutations. Ten isolates from each hospital were then chosen at random for molecular typing.
RESULTS: The isolates showed good susceptibility to all five anti-MRSA agents; only five sporadic non-susceptible isolates were detected. CC5/ST5-MRSA-II-t311 (39/120, 32.5%) was found to be the predominant HA-MRSA clone and was spread between the different hospitals in Hangzhou. CC5/ST5-MRSA-II-t002 was the most prevalent clone in Ningbo, while CC239/ST239-MRSA was epidemic only in certain hospitals in Wenzhou and Shaoxing. Fifteen ST59 isolates (15/120, 12.5%) were identified among the HA-MRSA isolates.
CONCLUSIONS: CC5/ST5-MRSA-II-t311 has become the predominant HA-MRSA clone in Hangzhou, Zhejiang Province. ST59 MRSA has spread into hospitals. The isolates showed good susceptibility to all five anti-MRSA agents.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antimicrobial susceptibility; Clonal complexes; Healthcare-associated methicillin-resistant Staphylococcus aureus; Molecular typing; Sequence type 5

Mesh:

Year:  2018        PMID: 29698703     DOI: 10.1016/j.ijid.2018.04.798

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Molecular epidemiology, genetic diversity and antimicrobial resistance of Staphylococcus aureus isolated from chicken and pig carcasses, and carcass handlers.

Authors:  Onyinye J Okorie-Kanu; Madubuike U Anyanwu; Ekene V Ezenduka; Anthony C Mgbeahuruike; Dipendra Thapaliya; Gracen Gerbig; Ejike E Ugwuijem; Christian O Okorie-Kanu; Philip Agbowo; Solomon Olorunleke; John A Nwanta; Kennedy F Chah; Tara C Smith
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

2.  Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China.

Authors:  Yingjian Liang; Changli Tu; Cuiyan Tan; Mohamed Abd El-Gawad El-Sayed Ahmed; Min Dai; Yong Xia; Yan Liu; Lan-Lan Zhong; Cong Shen; Guanping Chen; Guo-Bao Tian; Jing Liu; Xiaobin Zheng
Journal:  Infect Drug Resist       Date:  2019-02-25       Impact factor: 4.003

3.  Molecular characteristics and virulence gene profiles of Staphylococcus aureus isolates in Hainan, China.

Authors:  Xuehan Li; Tao Huang; Kai Xu; Chenglin Li; Yirong Li
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

4.  Genetic Characteristics of Multiple Copies of Tn1546-Like Elements in ermB-Positive Methicillin-Resistant Staphylococcus aureus From Mainland China.

Authors:  Haiping Wang; Dandan Wu; Lingfang Di; Feiteng Zhu; Zhengan Wang; Lu Sun; Yiyi Chen; Shengnan Jiang; Hemu Zhuang; Mengzhen Chen; Shujuan Ji; Yan Chen
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

5.  Mechanisms of high-level fosfomycin resistance in Staphylococcus aureus epidemic lineage ST5.

Authors:  Tianchi Chen; Lin Zhao; Yao Liu; Ya'nan Wang; Ying Jian; Na Zhao; Ziyu Yang; Xi Wang; Qian Liu; Min Li
Journal:  J Antimicrob Chemother       Date:  2022-09-30       Impact factor: 5.758

6.  Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005-2019).

Authors:  Yingjian Liang; Lidi Qiu; Xiaobin Zheng; Jing Liu
Journal:  Infect Drug Resist       Date:  2021-06-10       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.